Bausch Health Co. Inc. (BHC) Misses Q3 EPS by $1.26, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bausch Health Companies (BHC) PT Raised to $11 at RBC Capital
November 1, 2024 6:18 AM EDTRBC Capital analyst Doug Miehm raised the price target on Bausch Health Companies (NYSE: BHC) to $11.00 (from $10.00) while maintaining a Sector Perform rating.
The analyst comments "BHC reported Q3 results that were ahead of estimates led by strong performance across all segments. Reported... More
